GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1 receptor agonists, including Ozempic, Semaglutide, and Rybelsus, have surged over the last five years as their effectiveness in promoting weight loss gains attention beyond type 2 diabetes care
The report covers market size by value and volume, CAGR forecasts, and emerging opportunities, the report delivers Security Inks Market Set to hit US$ 5.03Bn by 2035, UV Inks, Government Security Security Inks Market stood at US$ 3.45 billion in 2025 and is expected to reach US$ 5.03 billion by 2035, growing with a CAGR of 3.8% during the forecast period 2026-2035
Will I need ongoing monitoring during treatment
Originally developed for Type 2 diabetes management, it has shown remarkable results in helping patients shed significant pounds by curbing hunger and increasing feelings of fullness